[1]
|
Lee RC, Feinbaum RL, Ambros V. The C.elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14[J].Cell, 1993, 75(5):843-854. |
[2]
|
Hagiwara K, Ochiya T, Kosaka N. A paradigm shift for extracellular vesicles as small RNA carriers:from cellular waste elimination to therapeutic applications[J].Drug Deliv Transl Res, 2014, 4:31-37. |
[3]
|
Sheherbata HR,Hatfield S,Ward EJ,et al.The MicroRNA pathway plays a regulatory role in stem cell division[J].Cell Cycle, 2006, 5(2):172-175. |
[4]
|
Hatfield SD, Sheherbata HR, Fischer KA, et al. Stem cell division is regulated by the microRNA pathway[J].Nature, 2005, 435(7044):974-978. |
[5]
|
Tan PH, Pao YY, Cheng JK, et al. MicroRNA-based therapy in pain medicine:current progress and future prospects[J].Acta Anaesthesiol Taiwanica, 2013, 51:171-176. |
[6]
|
Hatakeyama H, Murata M, Sato Y, et al. The systemic administration of an anti-miRNA oligonucleotide encapsulated pH-sensitive liposome results in reduced level of hepatic microRNA-122 in mice[J].J Control Rel, 2014, 173:43-50. |
[7]
|
Marshall E. Gene therapy death prompts review of adenovirus vector[J].Science, 1999, 286:2244-2245. |
[8]
|
Hollon T. Researchers and regulators reflect on first gene therapy death[J].Am J Ophthalmol, 2000, 129(5):701. |
[9]
|
Assessment of adenoviral vector safety and toxicity:report of the National Institutes of Health Recombinant DNA Advisory Committee [J].Hum Gene Ther, 2002, 13(1):3-13. |
[10]
|
Cavazzana Calvo M, Hacein Bey S, Basile G, et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease[J].Science, 2000, 288:669-672. |
[11]
|
Sanjoh M, Miyata K, Christie RJ, et al. Dual environment-responsive polyplex carriers for enhanced intracellulardelivery of plasmid DNA[J].Biomacromolecules, 2012, 13(11):3641-3649. |
[12]
|
Osada K, Shiotani T, Tockary TA, et al. Enhanced gene expression promoted by the quantized folding of pDNA within polyplex micelles[J].Biomaterials, 2012, 33(1):325-332. |
[13]
|
Sanjoh M, Hiki S, Lee Y, et al. pDNA/poly(L-lysine) polyplexes functionalized with a pH-sensitive charge-conversional poly(aspartamide) derivative for controlled gene delivery to human umbilical vein endothelial cells[J]. Macromol Rapid Commun. 2010, 31(13):1181-1186. |